Insulet Historical Income Statement

PODD Stock

USD 266.92 0.50 0.19%

Historical analysis of Insulet income statement accounts such as Research Development of 215.2 M, Ebitda of 339.8 M, Total Operating Expenses of 986.9 M or Net Income of 216.6 M can show how well Insulet performed in making a profits. Evaluating Insulet income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Insulet's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Insulet latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Insulet is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

About Insulet Income Statement Analysis

Insulet Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Insulet shareholders. The income statement also shows Insulet investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Insulet Income Statement Chart

At present, Insulet's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 263.3 M, whereas Total Other Income Expense Net is forecasted to decline to (5.7 M).

Other Operating Expenses Research Development Total Operating Expenses Income Tax Expense

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Insulet. It is also known as Insulet overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Insulet's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Insulet current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.At present, Insulet's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 263.3 M, whereas Total Other Income Expense Net is forecasted to decline to (5.7 M).

	2021	2022	2023	2024 (projected)
Interest Income	500K	9.8M	28.9M	30.3M
Tax Provision	3.7M	5.2M	9.1M	9.6M

Interest Income Tax Provision

Insulet income statement Correlations

	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Selling And Marketing Expenses	Depreciation And Amortization	Selling General Administrative	Total Revenue	Gross Profit	Cost Of Revenue	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Non Operating Income Net Other	Discontinued Operations	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Interest Expense		0.59	0.34	0.43	0.66	0.49	0.59	0.31	0.01	0.71	0.67	0.59	0.59	0.59	0.57	0.34	-0.78	0.45	-0.27	0.37	0.44	-0.31	0.61	-0.84	0.74
Other Operating Expenses	0.59		0.8	0.9	0.98	0.94	1.0	0.85	0.45	0.92	0.97	0.97	1.0	0.99	1.0	0.87	-0.2	0.91	0.19	0.39	0.96	0.41	0.73	-0.23	0.9
Operating Income	0.34	0.8		0.97	0.76	0.94	0.82	0.98	0.58	0.69	0.75	0.77	0.84	0.86	0.77	0.98	-0.01	0.95	0.1	0.34	0.9	0.67	0.52	0.06	0.62
Ebit	0.43	0.9	0.97		0.86	0.99	0.91	0.99	0.62	0.78	0.87	0.89	0.92	0.94	0.88	0.99	-0.08	0.98	0.14	0.37	0.97	0.62	0.58	-0.03	0.77
Research Development	0.66	0.98	0.76	0.86		0.9	0.98	0.81	0.45	0.97	0.96	0.94	0.98	0.98	0.97	0.83	-0.26	0.89	0.21	0.43	0.92	0.27	0.82	-0.36	0.91
Ebitda	0.49	0.94	0.94	0.99	0.9		0.95	0.97	0.6	0.82	0.92	0.93	0.96	0.97	0.92	0.97	-0.13	0.98	0.13	0.37	0.98	0.58	0.61	-0.1	0.82
Total Operating Expenses	0.59	1.0	0.82	0.91	0.98	0.95		0.86	0.47	0.93	0.97	0.97	1.0	1.0	0.99	0.89	-0.21	0.92	0.19	0.39	0.96	0.41	0.74	-0.24	0.9
Net Income	0.31	0.85	0.98	0.99	0.81	0.97	0.86		0.66	0.72	0.8	0.83	0.88	0.9	0.82	1.0	0.06	0.98	0.21	0.38	0.95	0.69	0.56	0.09	0.69
Income Tax Expense	0.01	0.45	0.58	0.62	0.45	0.6	0.47	0.66		0.26	0.45	0.53	0.48	0.5	0.41	0.61	0.09	0.57	0.04	0.23	0.6	0.44	0.22	0.04	0.49
Selling And Marketing Expenses	0.71	0.92	0.69	0.78	0.97	0.82	0.93	0.72	0.26		0.89	0.84	0.92	0.92	0.91	0.75	-0.27	0.83	0.28	0.43	0.83	0.15	0.88	-0.41	0.82
Depreciation And Amortization	0.67	0.97	0.75	0.87	0.96	0.92	0.97	0.8	0.45	0.89		0.98	0.97	0.97	0.97	0.82	-0.32	0.86	0.09	0.34	0.93	0.34	0.67	-0.35	0.95
Selling General Administrative	0.59	0.97	0.77	0.89	0.94	0.93	0.97	0.83	0.53	0.84	0.98		0.97	0.97	0.97	0.85	-0.28	0.87	0.07	0.35	0.94	0.42	0.63	-0.26	0.94
Total Revenue	0.59	1.0	0.84	0.92	0.98	0.96	1.0	0.88	0.48	0.92	0.97	0.97		1.0	0.99	0.9	-0.21	0.93	0.17	0.4	0.97	0.43	0.73	-0.22	0.89
Gross Profit	0.59	0.99	0.86	0.94	0.98	0.97	1.0	0.9	0.5	0.92	0.97	0.97	1.0		0.98	0.92	-0.21	0.95	0.16	0.4	0.98	0.44	0.73	-0.22	0.89
Cost Of Revenue	0.57	1.0	0.77	0.88	0.97	0.92	0.99	0.82	0.41	0.91	0.97	0.97	0.99	0.98		0.85	-0.2	0.88	0.2	0.38	0.95	0.41	0.71	-0.21	0.9
Income Before Tax	0.34	0.87	0.98	0.99	0.83	0.97	0.89	1.0	0.61	0.75	0.82	0.85	0.9	0.92	0.85		0.05	0.98	0.23	0.35	0.96	0.69	0.57	0.08	0.7
Total Other Income Expense Net	-0.78	-0.2	-0.01	-0.08	-0.26	-0.13	-0.21	0.06	0.09	-0.27	-0.32	-0.28	-0.21	-0.21	-0.2	0.05		-0.04	0.71	-0.25	-0.07	0.49	-0.2	0.86	-0.42
Net Income From Continuing Ops	0.45	0.91	0.95	0.98	0.89	0.98	0.92	0.98	0.57	0.83	0.86	0.87	0.93	0.95	0.88	0.98	-0.04		0.22	0.48	0.96	0.57	0.69	-0.05	0.76
Non Operating Income Net Other	-0.27	0.19	0.1	0.14	0.21	0.13	0.19	0.21	0.04	0.28	0.09	0.07	0.17	0.16	0.2	0.23	0.71	0.22		-0.01	0.19	0.21	0.37	0.4	0.0
Discontinued Operations	0.37	0.39	0.34	0.37	0.43	0.37	0.39	0.38	0.23	0.43	0.34	0.35	0.4	0.4	0.38	0.35	-0.25	0.48	-0.01		0.35	-0.07	0.62	-0.28	0.37
Tax Provision	0.44	0.96	0.9	0.97	0.92	0.98	0.96	0.95	0.6	0.83	0.93	0.94	0.97	0.98	0.95	0.96	-0.07	0.96	0.19	0.35		0.6	0.61	-0.06	0.84
Interest Income	-0.31	0.41	0.67	0.62	0.27	0.58	0.41	0.69	0.44	0.15	0.34	0.42	0.43	0.44	0.41	0.69	0.49	0.57	0.21	-0.07	0.6		-0.07	0.68	0.2
Extraordinary Items	0.61	0.73	0.52	0.58	0.82	0.61	0.74	0.56	0.22	0.88	0.67	0.63	0.73	0.73	0.71	0.57	-0.2	0.69	0.37	0.62	0.61	-0.07		-0.43	0.64
Net Interest Income	-0.84	-0.23	0.06	-0.03	-0.36	-0.1	-0.24	0.09	0.04	-0.41	-0.35	-0.26	-0.22	-0.22	-0.21	0.08	0.86	-0.05	0.4	-0.28	-0.06	0.68	-0.43		-0.46
Reconciled Depreciation	0.74	0.9	0.62	0.77	0.91	0.82	0.9	0.69	0.49	0.82	0.95	0.94	0.89	0.89	0.9	0.7	-0.42	0.76	0.0	0.37	0.84	0.2	0.64	-0.46

Click cells to compare fundamentals

Insulet Account Relationship Matchups

Insulet income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	26.8M	45.1M	61.2M	26.7M	36.2M	18.9M
Other Operating Expenses	688.2M	852.9M	972.8M	1.3B	1.5B	1.6B
Operating Income	22.1M	(600K)	66.7M	(26.7M)	220M	231M
Ebit	22.1M	54.9M	82.2M	46.3M	250.8M	263.3M
Research Development	129.7M	146.8M	160.1M	180.2M	205M	215.3M
Ebitda	50M	110.3M	139.6M	109.5M	323.6M	339.8M
Total Operating Expenses	430.3M	530.8M	626.1M	768M	939.9M	986.9M
Net Income	11.6M	6.8M	16.8M	4.6M	206.3M	216.6M
Depreciation And Amortization	27.9M	55.4M	57.4M	63.2M	72.8M	76.4M
Selling General Administrative	115.5M	384M	466M	587.8M	666.4M	699.7M
Total Revenue	738.2M	904.4M	1.1B	1.3B	1.7B	1.8B
Gross Profit	480.3M	582.3M	752.1M	805.6M	1.2B	1.2B
Cost Of Revenue	257.9M	322.1M	346.7M	499.7M	537.2M	564.1M
Income Before Tax	14.5M	9.7M	20.5M	9.8M	214.6M	225.3M
Total Other Income Expense Net	(7.6M)	(41.8M)	(105.5M)	(27.8M)	(5.4M)	(5.7M)
Net Income From Continuing Ops	11.6M	6.8M	16.8M	4.6M	120M	126M
Non Operating Income Net Other	(900K)	3.3M	(44.3M)	(1.1M)	(1.3M)	(1.3M)
Net Income Applicable To Common Shares	11.6M	6.8M	16.8M	4.6M	5.3M	5.6M
Interest Income	7.8M	3M	500K	9.8M	28.9M	30.3M
Net Interest Income	(26.8M)	(45.1M)	(61.2M)	(26.7M)	(9.8M)	(10.3M)
Reconciled Depreciation	27.9M	55.4M	57.4M	63.2M	70.2M	47.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:

How To Invest In Insulet

Details

Is Insulet Stock a good investment?

Details

What is Insulet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.46

Earnings Share

5.87

Revenue Per Share

28.341

Quarterly Revenue Growth

0.257

Return On Assets

0.0757

The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insulet Historical Income Statement

About Insulet Income Statement Analysis

Insulet Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Insulet income statement Correlations

Insulet Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Insulet income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Total Revenue	+ 1.0	Other Operating Expenses
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Revenue	+ 1.0	Total Operating Expenses
Gross Profit	+ 1.0	Total Operating Expenses
Income Before Tax	+ 1.0	Net Income

Net Interest Income	- 0.84	Interest Expense
Total Other Income Expense Net	- 0.78	Interest Expense
Reconciled Depreciation	- 0.46	Net Interest Income
Net Interest Income	- 0.43	Extraordinary Items
Reconciled Depreciation	- 0.42	Total Other Income Expense Net
Net Interest Income	- 0.41	Selling And Marketing Expenses